Theratechnologies Inc T.TH

Meanwhile AKRO.....a 2B$ company

[Joemare]

And that's how it's done. Waisted three years on NASH.....no results.....Accountability??

[Biobob]

No short term gain with Th1902 = Accountibility. It's payback time whatever excuse the find in case of lack of improvement in the stock price.  They must be reminded that whatever their personal endevours are that we are the reason of their existance.

[SPCEO1]

Odd to be focused on NASH less than a week before we hear something about cancer, which will almsot certainly be positive at some level. Why waist (; all that mental energy looking backward? 

[Joemare]

We shall forgive them for NASH should TH1902 lead to much better times.....But, I still want a PR before the 13th!

[SPCEO1]

Last quarter during the week of the conference call, if I recall correctly, they first announced the funding for further cancer research from that Canadian group, then the financing and then the somewhat expanded phase 1a data in the days before the 2Q conference call. Maybe we will get something like that next week too. Monday is a minor PR about the availability of the special water for the F8

[Biobob]

Oh well why not.... let's be Jolly and positive and tehy won't just give us a blant updtate like e have recruited our 7th patient and 13 have died and we beleive we have the key to the 8th patient... lol

[palinc2000]

It is  to be expected that some patients passed  during the trial but this is no laughing matter ... I dont understand your blaming management for how TH1902  performs in patients ... you want Paul to trabsform himself into a Peptide?  

[Biobob]

I expext nothing from them... what woudl you expect from a chimp... to monkey around maybe.

[Bucknelly21]

Has paul done anything unbecoming in your opinion palinc. You seem tp defend him on every matter

[Biobob]

Nash/Nothing, Legacy sales/Price inceases mostly, Th1902/Slow progress and no tangible value atm, Valuation is still mediocre, same CFO, no worthy anayst still, IR answering machine instead of engaging conversation.  Anyway let's wait and see if he can descend upon us next week... alleluia..

[Wino115]

Isn't your Complaint Basket overflowing by now? ;>)  Given it's Friday and you need some positivity so you won't kick your dog in the face this weekend, I think it's worth remembering that in FY2021, the FDA only designated 45 drug programs for Fast Track authority.  TH1902 was one of them. So out of the 600-700 programs commencing that year, this was one of the rare

[jfm1330]

I will say it again, you cannot talk about having the key without knowing if there is a lock that allows to open a door on the cancer cells you are trying to kill. In other words, they will need to adress the reality of sortilin overexpression related to any efficacy sign. We won't have any proof of concept without data about that critical aspect.

[qwerty22]

If there is a chemo party going on in the cell how did they all get in? Responders tell us an awful lot without knowing exactly what caused the response. From looking at SOC results in other trials you can see response rates as low as 5% and certainly below 20%. If you are getting good numbers of responders then you can assume something special is happening before you finally link that "

[palinc2000]

  I have zero science background but I know that cancers especially like the types of those in the trial are hard to treat... I dont have aby proof of course but I would  bet that if you have 10 patients in the trial with the same cancer type and about the same level of Sortilin Expression that they would not all react the same way to the Th 1902 .... so in the end Sortilin Expression